However, the IrxA cluster (IRX1, IRX2, and IRX4) showed a significantly greater increase in the LRRK2 G2019S PD patient-derived cells over the wild-type control cells compared to the IrxB cluster (IRX3, IRX5, and IRX6) in hNESs. This evidence concerns the gene IRX1 and Parkinson disease.